SAM.gov listing

Preclinical Assessment of Naloxone Adequacy to Reverse Polysubstance Use-Induced Respiratory Depression — In Vivo Validation

Agency
HEALTH AND HUMAN SERVICES, DEPARTMENT OF.FOOD AND DRUG ADMINISTRATION.FDA OFFICE OF ACQ GRANT SVCS
NAICS
541714
Set-aside
No Set aside used
Type
Presolicitation
Response deadline
2026-09-10T15:00:00-04:00
Assess this opportunity with CaptureIQGet SAM.gov alerts like this

View official listing on SAM.gov ↗

← All federal opportunities · Federal Opportunity Research